We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

$1.5 Million Cleveland Foundation Grant Continues to Build Proteomics Infrastructure at Case Western Reserve University

The funding will allow the university to develop customized technologies and research to make a significant impact on human health.
News

Cytori and GE Healthcare Form Partnership to Commercialize StemSource in the U.S

GE Healthcare to commercialize Cytori’s StemSource® technology in the North American stem cell banking and research markets.
News

Ancora Co-Founder Louis Schofield Receives $100,000 Grant from Gates Foundation

The collaboration accelerates Dr. Schofield and the Ancora team’s effort to create cost-effective malaria vaccines utilizing carbohydrate synthesis.
News

Covidien Announces Definitive Agreement to Acquire VNUS Medical Technologies

The acquisition of a developer of medical devices for minimally invasive treatment of venous reflux disease expands Covidien’s its presence in the vascular market.
News

Eurogentec Launches new Oligo Synthesis Facility

Key facility expands Eurogentec’s global business in the life science research, molecular diagnostic, and clinical laboratory markets.
News

Exelixis and Boehringer Ingelheim Enter into Collaboration for Development of S1P1 Receptor Agonists

Companies establish an exclusive, worldwide collaboration with the aim to discover, develop and commercialize autoimmune disease therapies.
News

Cellexus and Groton Collaborate on Use of Automated Sampling with Single-Use Bioreactors

Collaboration uses Groton’s automated sampler with the Cellexus single-use bioreactors for aseptic sample extraction from cell culture.
News

Evotec Acquires Zebrafish Screening Operations of Summit Corporation

The acquisition against £ 0.5 million cash in 2009 expected to add approximately £ 1.5 million revenues in 2010.
News

Evotec to Re-engineer Drug Discovery and Development Operations

Evotec to concentrate all proprietary core research programs at its European operations.
News

Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement

Both the companies gain right to exclusively license and/or sublicense a number of albumin fusion proteins in exchange for royalties and other consideration.
Advertisement